Key Takeaways
- •Antimicrobial peptides, small molecules found in nature, play a vital role in immune defenses.
- •Most antimicrobial peptides with defined secondary structures fit into four groups: β-sheet, α-helix, extended, or loop.
- •Well-known examples in the α-helix class include cyclic indolicin, protegrin, magainin, and coiled indolicin.
Natural Defenders Against Pathogens
Antimicrobial peptides, small molecules found in nature, play a vital role in immune defenses. They show strong activity against bacteria, viruses, fungi, and certain cancer cells. With antibiotic resistance on the rise, these peptides attract attention as potential supplements or substitutes for standard treatments.
Common Structural Forms
Most antimicrobial peptides with defined secondary structures fit into four groups: β-sheet, α-helix, extended, or loop. The α-helix and β-sheet types dominate, and α-helical forms have received the most study so far. In α-helix structures, adjacent amino acids sit about 0.15 nm apart, with each forming roughly a 100-degree angle from the center when viewed from above.
Well-known examples in the α-helix class include cyclic indolicin, protegrin, magainin, and coiled indolicin. β-sheet peptides feature disulfide bonds linking at least two β-strands. For detailed peptide structures, check the Peptide Glossary.
How They Target Membranes
These peptides attack microbial cell membranes through several steps. First, electrostatic forces draw them close, as the peptides carry positive charges and bacterial membranes hold negative phospholipids.
Next comes membrane penetration via models like Barrel-Stave, Carpet, or Toroidal-Pore. In the Barrel-Stave Model, peptides form barrel-shaped channels that boost permeability and cause content leakage, leading to cell death. The Carpet Model sees peptides coat the surface parallelly, reducing fluidity until rupture occurs. The Toroidal-Pore Model creates ring-shaped pores by drawing lipids inward, breaking membrane integrity.
Disruption follows, with leaks of cytoplasmic material and eventual cell rupture. Selective toxicity arises from stronger binding to bacterial lipids than human ones, sparing host cells. For planning experiments, tools like the Peptide Stability Calculator can help evaluate conditions.
Actions on Cell Walls
Peptidoglycan forms a key part of bacterial cell walls, and lipid II aids in moving its subunits across the membrane. Some peptides block wall synthesis and damage existing structures by binding lipid II. Studies show vancomycin, a glycopeptide, binds lipid II's C-terminal D-Ala-D-Ala site to prevent penicillin-binding proteins from attaching, halting gram-positive bacteria growth.
Nisin, a lantibiotic with five lanthionine rings, binds lipid II's pyrophosphate via rings A and B to form wall pores. These effects broaden options against resistant strains.
Intracellular Effects
Certain peptides enter bacterial cells directly, upsetting processes like DNA replication, translation, transcription, protein folding, and division. Entry happens through energy-dependent endocytosis or direct permeation, either by making holes or translocating amid instability.
Once inside and accumulated, they hit intracellular targets such as proteases, nucleic acids, and proteins. This multi-level action strengthens their impact. Researchers might use the Half-Life Calculator to model dosing in studies.
Combating Biofilms and Boosting Immunity
Biofilms, structured bacterial communities, resist antibiotics and contribute to up to two-thirds of human infections. Some peptides fight biofilms beyond free-floating cells, blocking adhesion or dismantling mature ones to improve antibiotic success.
They also tune immune responses by raising leukocyte chemokines for cell recruitment, mimicking chemokines at high doses. Peptides dampen inflammation via TLR pathways, useful in infections causing septic shock. Plus, they speed wound healing by drawing keratinocytes, epithelial cells, and producing metalloproteinases.
Anticancer Potential and Broader Promise
Select antimicrobial peptides act as anticancer peptides with targeted toxicity toward tumor cells. Their broad action covers gram-positive and gram-negative bacteria, fungi, and viruses.
By avoiding common resistance pathways, they counter multi-drug-resistant threats. Initial antimicrobial discovery sparked interest in them as a new antibiotic class.
In conclusion, antimicrobial peptides disrupt membranes, walls, and internals while offering antibiofilm, immune, and anticancer benefits. Their spectrum and selectivity make them valuable for research into resistant infections. Stay updated via latest peptide news.